Related Experiment Video
Updated: Jul 20, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
Cannabinoids in cancer pain management
1H. Lee Moffitt Cancer Center, Tampa, FL, USA. ahuskey@tampabay.rr.com
Cannabinoids show promise for managing cancer pain by interacting with the body's endocannabinoid system. Research explores their analgesic effects and other potential benefits in cancer care.
Area of Science:
- Oncology
- Pain Management
- Pharmacology
Background:
- Cancer pain is a significant challenge impacting patient quality of life.
- The endocannabinoid system plays a role in pain modulation.
- Cannabinoids are compounds derived from the cannabis plant with potential therapeutic properties.
Purpose of the Study:
- To review the clinical applications of cannabinoids in managing cancer pain.
- To discuss the role of the endocannabinoid system and cannabinoid receptors in analgesia.
- To explore other uses of cannabinoids in cancer care and related symptoms.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of research on cannabinoid receptor interactions.
- Discussion of evidence for analgesic effects.
Main Results:
- Cannabinoids interact with the endocannabinoid system to modulate pain signals.
- Evidence suggests cannabinoids possess analgesic properties relevant to cancer pain.
- Potential applications extend beyond pain to other cancer-related issues.
Conclusions:
- Cannabinoids represent a potential therapeutic option for cancer pain management.
- Further research is warranted to fully elucidate their efficacy and safety.
- Understanding the endocannabinoid system is key to optimizing cannabinoid-based therapies.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Analgesia and Pain Management
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists